Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / DCPH - Deciphera up 101% premarket on positive late-stage ripretinib data


DCPH - Deciphera up 101% premarket on positive late-stage ripretinib data

  • Thinly traded Deciphera Pharmaceuticals (NASDAQ:DCPH) is up 101% premarket on increased volume in reaction to positive topline results from a 129-subject Phase 3 clinical trial, INVICTUS, evaluating ripretinib, a broad-spectrum KIT and PDGFR? inhibitor, in patients with fourth-line and fourth-line plus gastrointestinal stromal tumors (GIST).
  • More news on: Deciphera Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: Deciphera Pharmaceuticals Inc.
Stock Symbol: DCPH
Market: NASDAQ
Website: deciphera.com

Menu

DCPH DCPH Quote DCPH Short DCPH News DCPH Articles DCPH Message Board
Get DCPH Alerts

News, Short Squeeze, Breakout and More Instantly...